In the first half of FY27, Indian investors shifted capital toward domestic sectors like realty, defense, and pharma, with indices gaining up to 30%. While strong local demand and government spending fueled this growth, the outlook for the second half is cautious. Investors are now watching how potential interest rate hikes and rising input costs could impact profit margins.
The first six months of the 2027 financial year have seen a clear change in investor strategy. As global geopolitical uncertainty has made many hesitant, capital has moved toward sectors that rely on domestic demand. Data shows that the Nifty Realty, Nifty India Defence, and Nifty Pharma indices have all recorded gains of up to 30 percent, reflecting this strong preference for local stability.
Why Domestic Sectors Are Leading
The move into these sectors is largely driven by concrete factors rather than just market sentiment. In defense, the government’s commitment to localized sourcing and a massive budgetary allocation of ₹7.85 trillion have provided a strong floor for company valuations. Similarly, the pharmaceutical sector has benefited from steady export growth, which has helped offset international volatility. This stands in sharp contrast to segments like Nifty IT, Nifty FMCG, and Nifty CPSE, which have struggled, with some indices seeing declines of up to 10 percent during the same period.
The Challenge of Rising Costs and Interest Rates
While the performance in the first half has been strong, the second half of the financial year brings new concerns. A primary monitorable for investors is the potential for interest rate hikes by the Reserve Bank of India in October 2026. Higher interest rates typically lead to more expensive home loans, which could slow down demand in the real estate sector.
Beyond interest rates, margin pressure is becoming a real risk. Inflation in the cost of raw materials, energy, and freight is affecting companies across the board. For instance, pharmaceutical companies are expected to face operating margin contraction of 150 to 200 basis points in the coming months. Real estate firms, while enjoying strong institutional investment, are also dealing with rising land and construction costs that could squeeze their profitability.
What Investors Should Track Next
The market is entering a phase where execution matters more than just having a large order book. As the initial excitement around domestic stories settles, the focus will shift to how well companies can manage their rising costs and deliver on their projects. Investors are likely to watch upcoming quarterly results closely to see if revenue growth can keep pace with inflationary pressure. Those looking at the real estate and pharma sectors will need to assess whether these companies can maintain their profit margins despite the increase in operational expenses.